Autologous Cell Therapy Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

Autologous Cell Therapy Market by Source (Autologous Cellular Immunotherapies, Autologous Stem Cell Therapy), Type (Bone Marrow, Epidermis, Mesenchymal stem cells, Haematopoietic stem cells, Chondrocytes, Others), Application (Cance, Neurodegenerative disorder, Cardiovascular disorder, Autoimmune disorder, Orthopedic, Wound healing, Others), End-user (Hospitals & Clinics, Ambulatory Centers, Academics & Research, Others), and Regional Analysis from 2026 to 2033

ID: PMRREP34713| 195 Pages | 30 Jan 2026 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Autologous Cell Therapy Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Autologous Cell Therapy Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Bn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
    3. Global Autologous Cell Therapy Market Outlook: Therapy
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Therapy, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2026 - 2033
        1. Autologous Cellular Immunotherapies
        2. Autologous Stem Cell Therapy
      4. Market Attractiveness Analysis: Therapy
    4. Global Autologous Cell Therapy Market Outlook: Source
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Source, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Source, 2026 - 2033
        1. Bone Marrow
        2. Epidermis
        3. Mesenchymal stem cells
        4. Haematopoietic stem cells
        5. Chondrocytes
        6. Others
      4. Market Attractiveness Analysis: Source
    5. Global Autologous Cell Therapy Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Application, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
        1. Cancer
        2. Neurodegenerative disorders
        3. Cardiovascular disorders
        4. Autoimmune disorders
        5. Orthopedics
        6. Wound healing
        7. Others
      4. Market Attractiveness Analysis: Application
    6. Global Autologous Cell Therapy Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By End User, 2020 - 2025
      3. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
        1. Hospitals & Clinics
        2. Ambulatory Centers
        3. Academics & Research
        4. Others
      4. Market Attractiveness Analysis: End User
  5. Global Autologous Cell Therapy Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Region, 2020 - 2025
    3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026 - 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Autologous Cell Therapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Therapy
      3. By Source
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2026 - 2033
      1. Autologous Cellular Immunotherapies
      2. Autologous Stem Cell Therapy
    5. Market Size (US$ Bn) Analysis and Forecast, By Source, 2026 - 2033
      1. Bone Marrow
      2. Epidermis
      3. Mesenchymal stem cells
      4. Haematopoietic stem cells
      5. Chondrocytes
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Cancer
      2. Neurodegenerative disorders
      3. Cardiovascular disorders
      4. Autoimmune disorders
      5. Orthopedics
      6. Wound healing
      7. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    8. Market Attractiveness Analysis
  7. Europe Autologous Cell Therapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Therapy
      3. By Source
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2026 - 2033
      1. Autologous Cellular Immunotherapies
      2. Autologous Stem Cell Therapy
    5. Market Size (US$ Bn) Analysis and Forecast, By Source, 2026 - 2033
      1. Bone Marrow
      2. Epidermis
      3. Mesenchymal stem cells
      4. Haematopoietic stem cells
      5. Chondrocytes
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Cancer
      2. Neurodegenerative disorders
      3. Cardiovascular disorders
      4. Autoimmune disorders
      5. Orthopedics
      6. Wound healing
      7. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    8. Market Attractiveness Analysis
  8. East Asia Autologous Cell Therapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Therapy
      3. By Source
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2026 - 2033
      1. Autologous Cellular Immunotherapies
      2. Autologous Stem Cell Therapy
    5. Market Size (US$ Bn) Analysis and Forecast, By Source, 2026 - 2033
      1. Bone Marrow
      2. Epidermis
      3. Mesenchymal stem cells
      4. Haematopoietic stem cells
      5. Chondrocytes
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Cancer
      2. Neurodegenerative disorders
      3. Cardiovascular disorders
      4. Autoimmune disorders
      5. Orthopedics
      6. Wound healing
      7. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Autologous Cell Therapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Therapy
      3. By Source
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2026 - 2033
      1. Autologous Cellular Immunotherapies
      2. Autologous Stem Cell Therapy
    5. Market Size (US$ Bn) Analysis and Forecast, By Source, 2026 - 2033
      1. Bone Marrow
      2. Epidermis
      3. Mesenchymal stem cells
      4. Haematopoietic stem cells
      5. Chondrocytes
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Cancer
      2. Neurodegenerative disorders
      3. Cardiovascular disorders
      4. Autoimmune disorders
      5. Orthopedics
      6. Wound healing
      7. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    8. Market Attractiveness Analysis
  10. Latin America Autologous Cell Therapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Therapy
      3. By Source
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2026 - 2033
      1. Autologous Cellular Immunotherapies
      2. Autologous Stem Cell Therapy
    5. Market Size (US$ Bn) Analysis and Forecast, By Source, 2026 - 2033
      1. Bone Marrow
      2. Epidermis
      3. Mesenchymal stem cells
      4. Haematopoietic stem cells
      5. Chondrocytes
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Cancer
      2. Neurodegenerative disorders
      3. Cardiovascular disorders
      4. Autoimmune disorders
      5. Orthopedics
      6. Wound healing
      7. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    8. Market Attractiveness Analysis
  11. Middle East & Africa Autologous Cell Therapy Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2020 - 2025
      1. By Country
      2. By Therapy
      3. By Source
      4. By Application
      5. By End User
    3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026 - 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Bn) Analysis and Forecast, By Therapy, 2026 - 2033
      1. Autologous Cellular Immunotherapies
      2. Autologous Stem Cell Therapy
    5. Market Size (US$ Bn) Analysis and Forecast, By Source, 2026 - 2033
      1. Bone Marrow
      2. Epidermis
      3. Mesenchymal stem cells
      4. Haematopoietic stem cells
      5. Chondrocytes
      6. Others
    6. Market Size (US$ Bn) Analysis and Forecast, By Application, 2026 - 2033
      1. Cancer
      2. Neurodegenerative disorders
      3. Cardiovascular disorders
      4. Autoimmune disorders
      5. Orthopedics
      6. Wound healing
      7. Others
    7. Market Size (US$ Bn) Analysis and Forecast, By End User, 2026 - 2033
      1. Hospitals & Clinics
      2. Ambulatory Centers
      3. Academics & Research
      4. Others
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. BrainStorm Cell Therapeutics
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Holostem Terapie Avanzate S.R.L
      3. Pharmicell Co. Inc
      4. Opexa Therapeutics
      5. Lonza
      6. Bristol Myers Squibb
      7. Tego Science
      8. Corning Incorporated
      9. Bio Elpida
      10. Novartis
      11. Autolus therapeutics
      12. Vericel Corporation
      13. Catalent, Inc
      14. Sartorius AG
      15. Caladrius Biosciences Inc
      16. U.S. Stem Cell Inc
      17. Others
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate